Clinical economics review: cost-effectiveness in the therapy of liver disease.
There have been many advances made in the management of patients with liver disease both in diagnosis and in the treatment of underlying liver disease and its complications, although comparatively few of these have been rigorously subjected to full cost-effectiveness evaluation. In this review, we have analysed a small number of the therapeutic interventions; while these have been well evaluated clinically, very few have been analysed from the viewpoint of cost-effectiveness and, thus, it is difficult to make many definitive claims. It is hoped that future studies will consider these aspects as well.
Neuberger
J
J
The Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
Bryan
S
S
D001201:Ascites / Q000191:economics / Q000628:therapy; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D004932:Esophageal and Gastric Varices / Q000191:economics / Q000628:therapy; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000191:economics* / Q000628:therapy*; D006113:United Kingdom